3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
26
Prostatic Neoplasms
5
Osteosarcoma
5
Neuroendocrine Tumors
5
Neoplasms
5
Kidney Neoplasms
5
Colorectal Neoplasms
5
Carcinoma, Hepatocellular
5
Neoplasm Metastasis
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Sarcoma, Ewing
3
Sarcoma
3
Clear-cell metastatic renal cell carcinoma
3
Carcinoma, Transitional Cell
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Medullary
3
Urogenital Neoplasms
2
Ureteral Neoplasms
2
Small Cell Lung Carcinoma
2
Penile Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma
2
Adrenocortical Carcinoma
2
von Hippel-Lindau Disease
1
Wilms Tumor
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Interventions
fludarabine
25
Cyclophosphamide
20
Azacitidine
20
venetoclax
18
Specimen Handling
18
fludarabine phosphate
17
Mycophenolic Acid
14
Melphalan
14
Busulfan
14
Biopsy
14
Whole-Body Irradiation
13
Tacrolimus
12
Cytarabine
12
Granulocyte Colony-Stimulating Factor
10
decitabine and cedazuridine drug combination
9
Decitabine
9
Stem Cell Transplantation
8
Sirolimus
8
Injections
8
Filgrastim
8
Cyclosporine
8
Peripheral Blood Stem Cell Transplantation
7
Thiotepa
6
ruxolitinib
5
X-Rays
5
Idarubicin
5
Magnetic Resonance Spectroscopy
4
Cladribine
4
CPX-351
4
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
cabozantinib
×
90 days
×
Clear all
No trials found.